Viewing Study NCT05987527

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2026-03-09 @ 4:38 PM
Study NCT ID: NCT05987527
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-04
First Post: 2023-06-30
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)
Sponsor: Sangamo Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Transplant Rejection View
None End Stage Renal Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Regulatory T-Cells View
None Genetically modified cells View
None Chimeric antigen receptor View
None Long term follow up View
None T-Regs View
None Cell Therapy View